NeoGenomics, Inc. (NEO)

Price$8.23

Favorite Metrics

Price vs S&P 500 (26W)-18.77%

Price vs S&P 500 (4W)-6.53%

Market Capitalization$1.06B

All Metrics

P/CF (Annual)203.28x

Book Value / Share (Quarterly)$6.49

P/TBV (Annual)2.77x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)12.58%

Cash Flow / Share (Quarterly)$-0.17

Price vs S&P 500 (YTD)-33.95%

Gross Margin (TTM)43.21%

Net Profit Margin (TTM)-14.85%

EPS (TTM)$-0.84

10-Day Avg Trading Volume2.40M

EPS Excl Extra (TTM)$-0.84

Revenue Growth (5Y)10.35%

EPS (Annual)$-0.84

ROI (Annual)-9.17%

Gross Margin (Annual)43.21%

Net Profit Margin (5Y Avg)-14.33%

Cash / Share (Quarterly)$1.24

Revenue Growth QoQ (YoY)10.56%

ROA (Last FY)-7.94%

Revenue Growth TTM (YoY)10.11%

EBITD / Share (TTM)$-0.80

ROE (5Y Avg)-9.24%

Operating Margin (TTM)-15.93%

Cash Flow / Share (Annual)$-0.17

P/B Ratio1.27x

P/B Ratio (Quarterly)1.82x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)1.71x

Net Interest Coverage (TTM)-105.20x

ROA (TTM)-7.54%

EV / EBITDA (TTM)194.59x

EPS Incl Extra (Annual)$-0.84

Current Ratio (Annual)4.26x

Quick Ratio (Quarterly)3.70x

3-Month Avg Trading Volume1.88M

52-Week Price Return-13.82%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$4.26

P/S Ratio (Annual)1.46x

Asset Turnover (Annual)0.53x

52-Week High$13.74

Operating Margin (5Y Avg)-20.71%

EPS Excl Extra (Annual)$-0.84

CapEx CAGR (5Y)-1.48%

Tangible BV CAGR (5Y)-0.84%

26-Week Price Return-11.88%

Quick Ratio (Annual)3.70x

13-Week Price Return-35.85%

Total Debt / Equity (Annual)0.41x

Current Ratio (Quarterly)4.26x

Enterprise Value$1,245.402

Revenue / Share Growth (5Y)7.39%

Asset Turnover (TTM)0.51x

Book Value / Share Growth (5Y)0.93%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)14.93x

Pretax Margin (Annual)-15.16%

Cash / Share (Annual)$1.24

3-Month Return Std Dev48.46%

Gross Margin (5Y Avg)40.79%

Net Income / Employee (TTM)$-0

ROE (Last FY)-12.91%

Net Interest Coverage (Annual)-43.50x

EPS Basic Excl Extra (Annual)$-0.84

P/FCF (TTM)73.09x

Receivables Turnover (TTM)4.69x

Total Debt / Equity (Quarterly)0.41x

EPS Incl Extra (TTM)$-0.84

Receivables Turnover (Annual)4.69x

ROI (TTM)-8.67%

P/S Ratio (TTM)1.46x

Pretax Margin (5Y Avg)-15.63%

Revenue / Share (Annual)$5.68

Tangible BV / Share (Annual)$4.26

Forward P/E48.31x

Price vs S&P 500 (52W)-48.45%

Year-to-Date Return-30.02%

5-Day Price Return-1.44%

EPS Normalized (Annual)$-0.84

ROA (5Y Avg)-5.34%

Net Profit Margin (Annual)-14.85%

Month-to-Date Return10.92%

Cash Flow / Share (TTM)$-0.19

EBITD / Share (Annual)$-0.62

Operating Margin (Annual)-15.93%

LT Debt / Equity (Annual)0.41x

P/CF (TTM)203.28x

ROI (5Y Avg)-6.10%

LT Debt / Equity (Quarterly)0.41x

EPS Basic Excl Extra (TTM)$-0.84

P/TBV (Quarterly)2.77x

P/B Ratio (Annual)1.82x

Inventory Turnover (TTM)14.93x

Pretax Margin (TTM)-15.16%

Book Value / Share (Annual)$6.49

Price vs S&P 500 (13W)-38.23%

Beta1.77x

P/FCF (Annual)318.31x

Revenue / Share (TTM)$5.65

ROE (TTM)-12.64%

52-Week Low$4.72

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.61

3.53

3.61

Industry Peers — Testing Laboratories(2)

Symbol	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
NEONeoGenomics, Inc.	—	-12.64%	10.35%	—	$8.23
ULSUL Solutions Inc.	56.74x	28.77%	—	0.58%	$92.98
BNBXBNB Plus Corp. Common Stock	—	-320.25%	2.04%	—	$0.56

About

NeoGenomics Inc provides comprehensive oncology diagnostic testing and services through laboratories in the United States and United Kingdom. The company's offerings include clinical cancer testing, molecular and next-generation sequencing testing, professional interpretation, consultative services, clinical trial support, validation services, and oncology data solutions.